WAL 801 CL dry syrup

DRUG2 trials

Sponsors

Boehringer Ingelheim

Conditions

Dermatitis, Atopic

Phase 3

WAL 801 CL Dry Syrup in Paediatric Atopic Dermatitis Patients

CompletedNCT02182557

Boehringer IngelheimDermatitis, Atopic

Start: 2001-06-30Updated: 2014-07-14

WAL 801 CL Dry Syrup in Pediatric Atopic Dermatitis Patients

CompletedNCT02182570

Boehringer IngelheimDermatitis, Atopic

Start: 2001-06-30Updated: 2014-07-14